Calculate your body mass index (BMI)
Rheumatoid Arthritis/Systemic Lupus Erythematosus-238392 Part A
Visit dates are flexible
● Smoking (Yes)
● Smoking (No)
Up to: $935
Male, Female, Smoker, Non-Smoker
17.5 - 40
The purpose of this study is to assess the safety and tolerability of an investigational drug in subjects with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE). The study drug is a type of antibody that is directed against a specific receptor within the immune system that has been found to be involved in systemic autoimmune diseases such as SLE and RA.
Volunteers in the study will receive a single dose of the study drug via an IV (intravenous) infusion. To determine if you qualify for the study you must first complete a screening visit.
Participation in this study involves 1 screening visit, 1 inpatient admission to our clinic for 2 days/1 night for dosing, and a minimum of 8 outpatient visits spread out over 16 weeks.